842 An open, single dose, anti-tumour effect study of 2-hydroxyflutamide as a controlled release product (Liproca® Depot) injected into the prostate in patients with localized prostate cancer

2016 ◽  
Vol 15 (3) ◽  
pp. e842
Author(s):  
T. Tammela ◽  
A. Bjartell ◽  
M. Häggman
Keyword(s):  
Prostate Cancer ◽  
Single Dose ◽  
Controlled Release ◽  
Effect Study ◽  
Localized Prostate Cancer ◽  
Release Product ◽  
Anti Tumour Effect

Late Toxicity after Single Dose HDR Prostate Brachytherapy and EBRT for Localized Prostate Cancer: Clinical and Dosimetric Predictors in a Prospective Cohort Study

Brachytherapy ◽  
2018 ◽  
Vol 17 (4) ◽  
pp. S74
Author(s):  
David Büchser ◽  
Alfonso Gomez-Iturriaga ◽  
Alejandro Maleta ◽  
Francisco Casquero ◽  
Jose Maria Espinosa ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cohort Study ◽  
Single Dose ◽  
Prospective Cohort Study ◽  
Prospective Cohort ◽  
Late Toxicity ◽  
Localized Prostate Cancer ◽  
Prostate Brachytherapy

1141: A Randomized Controlled Trial Comparing External Beam Radiation and Cryoablation in Localized Prostate Cancer

2007 ◽  
Vol 177 (4S) ◽  
pp. 376-377 ◽  
Author(s):  
Bryan J. Donnelly ◽  
John C. Saliken ◽  
Penny Brasher ◽  
Scott Ernst ◽  
Harold Lau ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Localized Prostate Cancer ◽  
External Beam Radiation ◽  
External Beam ◽  
Beam Radiation ◽  
Randomized Controlled

140: Racial Differences in Clinical Progression Among Medicare Recipients after Treatment for Clinically Localized Prostate Cancer

2006 ◽  
Vol 175 (4S) ◽  
pp. 45-46
Author(s):  
Jacob H. Cohen ◽  
Victor J. Schoenbach ◽  
Jay S. Kaufman ◽  
James A. Talcott ◽  
Paul A. Godley
Keyword(s):  
Prostate Cancer ◽  
Racial Differences ◽  
Localized Prostate Cancer ◽  
Clinical Progression
Sign in / Sign up

Export Citation Format

Share Document